Author:
Zahorowska Beata,Crowe Philip J.,Yang Jia-Lin
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference82 articles.
1. Amann J, Kalyankrishna S, Masson PP et al (2005) Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res 65(1):226–235
2. Ariyama H, Qin B, Baba E et al (2006) Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells. J Cell Biochem 97(4):724–734. doi: 10.1002/jcb.20678
3. Arora A, Scholar EM (2005) Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther 315(3):971–979. doi: 10.1124/jpet.105.084145
4. Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillio F, Ciardiello F (2007) Erlotinib in cancer treatment. Ann Oncol 18(Suppl 6):vi35–vi41. doi: 10.1093/annonc/mdm222
5. Boccellino M, Giuberti G, Quagliuolo L et al (2004) Apoptosis induced by interferon-α and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells. J Cell Physiol 201(1):73–83. doi: 10.1002/jcp.20058
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献